| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |